🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06863051
Recruiting Not applicable

Effect of Albumin Platelet-Rich Fibrin or Leucocyte- Platelet-Rich Fibrin on Immediate Implant

NCT06863051 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-08-20
Last updated
2025-08-01

Condition(s) studied

Immediate Implant Placement

Investigational drug(s) / intervention(s)

Immediate Implant Placement and Alb-PRFImmediate Implant Placement and L-PRF

Immediate Implant Placement and Alb-PRF: Immediate Implant Placement in lower molar region, Grafted with Xenograft and Albumin PRF Gel

Immediate Implant Placement and L-PRF: Immediate Implant Placement in lower molar region, Grafted with Xenograft and L-PRF

Study summary

The objective of this study will be to compare between Immediate Implant grafted with xenograft and Alb-PRF gel versus xenograft with L-PRF.

Eligibility

Sex
ALL
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
1. Inclusion criteria * The presence of non-restorable mandibular molar. * Patient 18-45 years old * Intact buccal and lingual walls * Good oral hygiene. * Prescence of sufficient restorative space. * Jumping gap more than 2 mm. 2. Exclusion criteria * Proximity of anatomical structures * Acute localized infection (suppuration at the surgical field) * Patients on chemotherapy or radiotherapy. * Patients who have systemic disorders (diseases) {diabetes mellitus, autoimmune disease, …etc}, * Pregnant patients. * Smoking and Alcohols. * Presence of periapical pathology affecting the neighboring teeth.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kafrelsheikh University, Faculty of Dentistry Kafr ash Shaykh Kafrelsheikh Recruiting

More Kafrelsheikh University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06863051 on ClinicalTrials.gov ↗ ← All trials in Egypt